We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
160 hedge funds and large institutions have $2.16B invested in Acadia Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 62 increasing their positions, 56 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,265% more call options, than puts
Call options by funds: $297M | Put options by funds: $21.8M
11% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 56
2% less capital invested
Capital invested by funds: $2.21B → $2.16B (-$46.1M)
5% less funds holding
Funds holding: 168 → 160 (-8)
28% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 25
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
160
Holders Change
-8
Holders Change %
-4.76%
% of All Funds
4.6%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
18
Increased
62
Reduced
56
Closed
25
Calls
$297M
Puts
$21.8M
Net Calls
+$275M
Net Calls Change
-$36.5M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$66.4M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$30.2M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$24.2M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$18.4M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$13.7M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$15M |
| 2 |
HM
HealthCor Management
New York
|
-$10.1M |
| 3 |
TCP
Tourbillon Capital Partners
New York
|
-$8.52M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$8.29M |
| 5 |
HH
HWG Holdings
Houston,
Texas
|
-$7.59M |
